Official Publications GenSight Biologics S.A.

Equities

Market Closed - Euronext Paris Other stock markets 11:35:12 2024-05-10 am EDT			5-day change	1st Jan Change
0.391 ^EUR	-2.37%		-1.01%	-15.00%

May. 07	GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding	CI
Apr. 05	GenSight: financial visibility assured until the end of April	CF

Combined general shareholders meeting	Apr. 23	CO
Universal registration document	Apr. 16	CO
Annual results	Mar. 22	CO
Annual results	Mar. 21	CO
Threshold crossings	Feb. 15	CO
Corporate officers' Statement -: xercise of Stock Options 4	Feb. 08	CO
4th quarter turnover	Jan. 24	CO
4th quarter turnover	Jan. 24	CO
Changes in management and corporate officers	Jan. 15	CO
Threshold crossings	Jan. 08	CO
Changes in management and corporate officers	Dec. 21	CO
Changes in management and corporate officers	Dec. 21	CO
Extraordinary general Shareholders meeting notice	Dec. 21	CO
Extraordinary general Shareholders meeting	Dec. 05	CO
Threshold crossings	Nov. 23	CO
Amendment to the universal registration document	Nov. 21	CO
3rd quarter turnover	23-10-25	CO
3rd quarter turnover	23-10-25	CO
Half-year report	23-09-17	CO
1st-half-year results	23-09-14	CO
1st-half-year results	23-09-14	CO
Corporate officers' Statement -: xercise of Stock Options 4	23-08-30	CO
Periodical releases - commercial and industrial companies - annual accounts	23-08-06	CO
Shareholders meeting voting results	23-06-20	CO
General assembly meeting brochure	23-05-30	CO